Emmanuel Bey

535 total citations
13 papers, 484 citations indexed

About

Emmanuel Bey is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Emmanuel Bey has authored 13 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Emmanuel Bey's work include Estrogen and related hormone effects (12 papers), Hormonal Regulation and Hypertension (12 papers) and Steroid Chemistry and Biochemistry (4 papers). Emmanuel Bey is often cited by papers focused on Estrogen and related hormone effects (12 papers), Hormonal Regulation and Hypertension (12 papers) and Steroid Chemistry and Biochemistry (4 papers). Emmanuel Bey collaborates with scholars based in Germany, Egypt and United Kingdom. Emmanuel Bey's co-authors include Martin Frotscher, Sandrine Marchais‐Oberwinkler, Rolf W. Hartmann, Patricia Kruchten, Alexander Oster, Ruth Werth, Matthias Negri, Barbara Birk, Yaseen A. Al‐Soud and Alexander Neugebauer and has published in prestigious journals such as PLoS ONE, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Emmanuel Bey

13 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Bey Germany 11 306 295 159 137 67 13 484
Alexander Oster Germany 10 345 1.1× 325 1.1× 150 0.9× 172 1.3× 65 1.0× 10 550
Patricia Kruchten Germany 12 414 1.4× 395 1.3× 205 1.3× 184 1.3× 81 1.2× 13 621
Ruth Werth Germany 12 439 1.4× 414 1.4× 181 1.1× 215 1.6× 79 1.2× 14 675
Marie Wetzel Germany 8 220 0.7× 211 0.7× 66 0.4× 120 0.9× 46 0.7× 8 366
Mausumi Mazumdar Canada 7 198 0.6× 143 0.5× 49 0.3× 193 1.4× 41 0.6× 10 375
Liviu C. Ciobanu Canada 12 276 0.9× 88 0.3× 116 0.7× 308 2.2× 32 0.5× 13 417
Ivonne Heuze Mexico 14 134 0.4× 177 0.6× 51 0.3× 184 1.3× 25 0.4× 28 391
Robert I. Higuchi United States 11 164 0.5× 143 0.5× 218 1.4× 148 1.1× 27 0.4× 18 446
Achille Panzeri Italy 11 89 0.3× 105 0.4× 79 0.5× 121 0.9× 26 0.4× 18 327
Dao‐Wei Zhu Canada 12 202 0.7× 241 0.8× 54 0.3× 257 1.9× 63 0.9× 23 512

Countries citing papers authored by Emmanuel Bey

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Bey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Bey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Bey more than expected).

Fields of papers citing papers by Emmanuel Bey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Bey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Bey. The network helps show where Emmanuel Bey may publish in the future.

Co-authorship network of co-authors of Emmanuel Bey

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Bey. A scholar is included among the top collaborators of Emmanuel Bey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Bey. Emmanuel Bey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Abdelsamie, Ahmed S., Chris J. van Koppen, Emmanuel Bey, et al.. (2016). Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC 50 for a proof-of-principle study. European Journal of Medicinal Chemistry. 127. 944–957. 15 indexed citations
2.
Abdelsamie, Ahmed S., et al.. (2015). Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme. European Journal of Medicinal Chemistry. 103. 56–68. 11 indexed citations
3.
Abdelsamie, Ahmed S., Emmanuel Bey, Nina Hanke, et al.. (2014). Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker. European Journal of Medicinal Chemistry. 82. 394–406. 10 indexed citations
4.
Negri, Matthias, et al.. (2012). Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1). PLoS ONE. 7(1). e29252–e29252. 28 indexed citations
5.
Oster, Alexander, Tobias Klein, Ruth Werth, et al.. (2010). Novel estrone mimetics with high 17β-HSD1 inhibitory activity. Bioorganic & Medicinal Chemistry. 18(10). 3494–3505. 28 indexed citations
6.
Kruchten, Patricia, Ruth Werth, Emmanuel Bey, et al.. (2009). Selective inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17βHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 114(3-5). 200–206. 35 indexed citations
7.
Kruchten, Patricia, Ruth Werth, Sandrine Marchais‐Oberwinkler, et al.. (2009). Development of biological assays for the identification of selective inhibitors of estradiol formation from estrone in rat liver preparations. Comptes Rendus Chimie. 12(10-11). 1110–1116. 10 indexed citations
8.
Bey, Emmanuel, Sandrine Marchais‐Oberwinkler, Matthias Negri, et al.. (2009). New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity. Journal of Medicinal Chemistry. 52(21). 6724–6743. 69 indexed citations
9.
Al‐Soud, Yaseen A., Emmanuel Bey, Alexander Oster, et al.. (2008). The role of the heterocycle in bis(hydroxyphenyl)triazoles for inhibition of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) type 1 and type 2. Molecular and Cellular Endocrinology. 301(1-2). 212–215. 25 indexed citations
11.
Bey, Emmanuel, Sandrine Marchais‐Oberwinkler, Patricia Kruchten, et al.. (2008). Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases. Bioorganic & Medicinal Chemistry. 16(12). 6423–6435. 62 indexed citations
12.
Marchais‐Oberwinkler, Sandrine, Patricia Kruchten, Martin Frotscher, et al.. (2008). Substituted 6-Phenyl-2-naphthols. Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Design, Synthesis, Biological Evaluation, and Pharmacokinetics. Journal of Medicinal Chemistry. 51(15). 4685–4698. 59 indexed citations
13.
Jazbutyte, Virginija, Kai Hu, Patricia Kruchten, et al.. (2006). Aging Reduces the Efficacy of Estrogen Substitution to Attenuate Cardiac Hypertrophy in Female Spontaneously Hypertensive Rats. Hypertension. 48(4). 579–586. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026